Treatment of children with "ordinary" epilepsy

P R Camfield1, C S Camfield

  • 1Department of Pediatrics, Dalhousie University, Nova Scotia, Canada.

Insights

Many children with epilepsy experience seizure remission without medication. Treatment decisions for pediatric epilepsy should be individualized, as routine monitoring offers no proven benefit for asymptomatic children.

Area of Science:

  • Pediatric Neurology
  • Epileptology

Background:

  • Epilepsy in children often has a benign course with eventual remission.
  • Identifying children who will remit is challenging at diagnosis.
  • Treatment decisions are often influenced by fears rather than absolute indications.

Purpose of the Study:

  • To evaluate the necessity and approach to treating childhood epilepsy.
  • To inform clinical decision-making regarding antiepileptic drug (AED) initiation and cessation.
  • To assess the utility of routine monitoring in pediatric epilepsy management.

Main Methods:

  • Review of clinical course and treatment outcomes in children with epilepsy.
  • Analysis of factors influencing treatment decisions.
  • Evaluation of evidence for routine laboratory screening and serum drug level monitoring.

Main Results:

  • Not all children with epilepsy require treatment; many achieve remission.
  • Routine blood and urine screening for asymptomatic children offers no proven benefit.
  • Serum drug level monitoring has limited clear benefit.
  • Stopping medication after 6-12 months of seizure freedom is reasonable, with rare loss of seizure control upon recurrence.

Conclusions:

  • Individualized assessment is crucial for treatment decisions in pediatric epilepsy.
  • Routine toxicity screening and serum drug level monitoring are not beneficial for asymptomatic children.
  • A significant proportion of children with epilepsy can achieve remission and discontinue AEDs successfully.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...